4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-087549
Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
- Interim CEO & General Counsel acquired 52,086 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2025-09-02 | Option exercise | +52,086 | 456,690 | D | ||
| Vogt Frederick G Interim CEO & General Counsel | 2025-09-02 | Shares withheld for taxes | −22,127 | $2.19 | $48,458 | 434,563 | D |
| Derivatives | |||||||
| Vogt Frederick G Interim CEO & General Counsel | 2025-09-02 | Option exercise · Restricted Stock Units | −10,417 | 20,385 | D | ||
| Vogt Frederick G Interim CEO & General Counsel | 2025-09-02 | Option exercise · Restricted Stock Units | −41,669 | 250,013 | D | ||
Loading xslF345X05/tm2525186-4_4seq1.xml…